SEC Company Response from OSCIENT PHARMACEUTICALS CORP (CIK 0000356830) — Dec 3, 2004
OSCIENT PHARMACEUTICALS CORP (CIK 0000356830)
Date: Dec. 3, 2004 · CIK: 0000356830 · Accession: 0001193125-04-207303
AI Filing Summary & Sentiment
File numbers found in text: 333-118026
Letter
Division of Corporation Finance United States Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Oscient Pharmaceuticals Corporation.—Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-118026)
Dear Mr. Belliston:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oscient Pharmaceuticals Corporation (the “Company”), hereby requests that the Company’s Registration Statement on Form S-3 (File No. 333-118026) be declared effective at 4 p.m. Eastern Time on December 6, 2004 or as soon as possible thereafter.
The Company acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any actions with respect to the filing, (ii) the action of the Commission or the staff pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing, and (iii) the Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Please call Matthew Choate of Ropes & Gray LLP at (617) 951-7153 if you have any questions. Thank you for your assistance.
Very truly yours,
OSCIENT PHARMACEUTICALS CORPORATION
Show Raw Text
CORRESP 1 filename1.htm ACCELERATION REQUEST Oscient Pharmaceuticals Corporation 1000 Winter Street, Suite 2200 Waltham, MA 02451 December 3, 2004 Mr. Gregory S. Belliston Division of Corporation Finance United States Securities and Exchange Commission 450 Fifth Street, N.W. Washington, D.C. 20549 Re: Oscient Pharmaceuticals Corporation.—Request for Acceleration of Effectiveness of Registration Statement on Form S-3 (File No. 333-118026) Dear Mr. Belliston: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Oscient Pharmaceuticals Corporation (the “Company”), hereby requests that the Company’s Registration Statement on Form S-3 (File No. 333-118026) be declared effective at 4 p.m. Eastern Time on December 6, 2004 or as soon as possible thereafter. The Company acknowledges that (i) should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any actions with respect to the filing, (ii) the action of the Commission or the staff pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing, and (iii) the Company may not assert this action as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Please call Matthew Choate of Ropes & Gray LLP at (617) 951-7153 if you have any questions. Thank you for your assistance. Very truly yours, OSCIENT PHARMACEUTICALS CORPORATION By: /S/ STEVEN M. RAUSCHER Name: Steven M. Rauscher Title: President and Chief Executive Officer